Skip to main content
. 2018 Nov 19;13(11):e0207134. doi: 10.1371/journal.pone.0207134

Table 1. Characterization of GES-5 producing P. aeruginosa isolates, including MIC ranges, MLST, drug-resistant factors and virulent factors.

MLST No. of
isolatesa
MIC Range against antibioticsb (mg/L)
(% resistance)c
Carbapenemase- and
ESBL-
encoding gene(s)
Aminoglycoside resistance
gene(s)
Mutation in
DNA gyrase
Exotoxin
gene(s)
AMK AZT FEP CAZ CIP CST IMP MEM GyrA ParC
ST235
and ST2233 (CC235)
102 4–64
(47%)
2–64
(25%)
4–128
(17%)
4–512
(31%)
2–64
(99%)
0.063–0.5
(0%)
16–64
(100%)
32–512
(100%)
blaGES-5
blaPAO
blaOXA-488
aac(6')-Ib T83I S87L exoT
exoU
exoY
ST274 1 128 128 64 128 32 0.5 64 64 blaGES-5
blaPAO
blaOXA-486
aac(6')-Ia T83I S87L exoS
exoT
exoY
ST1342 1 64 64 32 64 32 0.5 64 128 blaGES-5
blaPAO
blaOXA-396
blaCMY-8
aac(6')-Ia T83I S87L exoS
exoT
exoY

aOf 102 isolates belonging to CC235, 99 isolates belonged to ST235 and the remaining 3 did to ST2233.

bAMK: Amikacin, AZT: Aztreonam, FEP: Cefepime, CAZ: Ceftazidime, CIP: Ciprofloxacin, CST: Colistin, IMP: Imipenem, MEM: Meropenem.

cBreakpoints for resistance (mg/L): AMK; ≥32, AZT; ≥32, FEP; ≥32, CAZ; ≥32, CIP; ≥4, CST; ≥8, IMP; ≥8, and MEM; ≥8.